A molecule like GLP-2T might be a "balanced" agonist at the GLP-1R, activating both cAMP and -arrestin pathways to a similar degree
We show readers that GLP-1RAs have also been found to significantly reduce the risks of heart failure, atherosclerosis (AS), and hypertension, highlighting their broad therapeutic potential
This register-based study utilized the Danish Administrative and Healthcare Registers to compare the risk of a new diagnosis of major CI or mild CI among individuals aged 65 or older exposed to DPP-4i versus those exposed to GLP-1a
Incretin-based treatments, which are widely used glucose-lowering drugs, have recently shown promise in improving cognitive functions among individuals with type-2 diabetes, positioning themselves as potential therapeutic agents for major CI [4, 5]
doi: 10.1016/j.eclinm.2024.102920 [DOI] [PMC free article] [PubMed] [Google Scholar] 45.Lhteenvuo M, Tiihonen J, Solismaa A, Tanskanen A, Mittendorfer-Rutz E, Taipale H
Every provider on the platform holds a valid medical license in the state where the patient is located